roxadustat

roxadustat

roxadustat FibroGen Receives Complete Response Letter from the FDA for Roxadustat for Anemia of Chronic Kidney Disease SAN FRANCISCO, Aug. 11,…

Read More
faricimab

faricimab

faricimab FDA Accepts Application for Genentech’s Faricimab for the Treatment of Wet Age-Related Macular Degeneration (AMD) and Diabetic Macular Edema…

Read More
ublituximab

ublituximab

ublituximab TG Therapeutics Announces FDA Acceptance of Biologics License Application for Ublituximab in Combination with Ukoniq (umbralisib) as a Treatment…

Read More